Are AKI Biomarkers Ready for Clinical Use?
Dr. Bihorac assesses whether to incorporate emerging AKI biomarkers into clinical practice based on evidence limitations and practical considerations.
COVID-19 and Renal Replacement Therapy
Host Pamela Peeke, MD, MPH, FACP, FACSM, is joined by Michael J. Connor, Jr .. MD to review RRT utilization and best practices during COVID-19, what hospitals are doing to prepare for surge in RRT, and how to mitigate anticoaguability in CRRT.View resource
AKI in Critically Ill Children
The importance of enhanced surveillance for acute kidney injury (AKI) in critically ill children and the implementation of monitoring for AKI.View resource
Medications and RRT: We Know How to Dose, Right?
Pharmacist and Professor Bruce Mueller discusses the difficulties of dosing patients with acute kidney injury and understanding how renal replacement can affect your antibiotics dosing.View resource